Cerebral thrombosis
Cerebral thrombosis (CT) is the most common type of cerebral infarction. It is caused by atherosclerosis of the main trunk or cortical branches of the cerebral arteries, which leads to vascular thickening, lumen stenosis and occlusion, and thrombosis, resulting in reduced blood flow or interruption of blood supply to the local brain, ischemia and hypoxia of brain tissue, leading to softening and necrosis, and the appearance of focal neurological symptoms and signs. Therefore, it is also called "atherosclerotic cerebral thrombosis" or "thrombotic cerebral infarction" in clinical practice.
-
Site of disease:
Brain -
Infectious :
Not contagious -
Frequent population:
The incidence rate in middle-aged and elderly men is higher than that in women -
Related symptoms:
Weakness Difficulty swallowing Hypersensitivity Sensory impairment Slow response -
Concurrent disease:
Related Drugs
Troxerutin Sodium Chloride Injection
Indication: It is used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), thrombophlebitis, central retinitis, edema caused by increased vascular permeability, etc.
Manufacturer:
Sichuan Pacific Pharmaceutical Co., Ltd.
Troxerutin Sodium Chloride Injection
Indication: It is used for ischemic cerebrovascular disease (such as cerebral thrombosis, cerebral embolism), thrombophlebitis, central retinitis, edema caused by increased vascular permeability, etc.
Manufacturer:
Xinhe Yuansheng MEDICINE Co., Ltd.
Ligustrazine Hydrochloride Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Manufacturer:
Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd.
Ligustrazine Hydrochloride Injection
Indication: Used for occlusive cerebrovascular diseases such as cerebral ischemia, cerebral thrombosis, cerebral embolism and other ischemic vascular diseases such as coronary heart disease, vasculitis, etc.
Cerebral thrombosis tablets
Manufacturer:
Tonghua Newdongri Pharmaceutical Co., Ltd.
Cerebral thrombosis tablets
Manufacturer:
Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
Cerebral thrombosis tablets
Manufacturer:
Hunan Zhengqing Pharmaceutical Co., Ltd.
Cerebral thrombosis tablets
Manufacturer:
Hainan Wanzhou Green Pharmaceutical Co., Ltd.
Ligustrazine Phosphate for Injection
Indication: Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by cerebral ischemia, cerebral thrombosis, and cerebral embolism.
Manufacturer:
Changchun Haiwang Biological Pharmaceutical Co., Ltd.
Ligustrazine Phosphate for Injection
Indication: Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by cerebral ischemia, cerebral thrombosis, and cerebral embolism.
Related Ingredients
-
Troxerutin list
7085-55-4 -
Ligustrazine Hydrochloride list
76494-51-4 -
Riligustilide list
89354-45-0 -
LigustrazinePhosphate list
848645-86-3